These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 1906377)

  • 21. Gene targeting of DT-diaphorase in mouse embryonic stem cells: establishment of null mutant and its mitomycin C-resistance.
    Yoshida T; Tsuda H
    Biochem Biophys Res Commun; 1995 Sep; 214(2):701-8. PubMed ID: 7677784
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mitomycin C is not metabolized by but is an inhibitor of human kidney NAD(P)H: (quinone-acceptor)oxidoreductase.
    Schlager JJ; Powis G
    Cancer Chemother Pharmacol; 1988; 22(2):126-30. PubMed ID: 3136941
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased DT-diaphorase expression and cross-resistance to mitomycin C in a series of cisplatin-resistant human ovarian cancer cell lines.
    O'Dwyer PJ; Perez RP; Yao KS; Godwin AK; Hamilton TC
    Biochem Pharmacol; 1996 Jul; 52(1):21-7. PubMed ID: 8678904
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unusually marked hypoxic sensitization to indoloquinone EO9 and mitomycin C in a human colon-tumour cell line that lacks DT-diaphorase activity.
    Plumb JA; Workman P
    Int J Cancer; 1994 Jan; 56(1):134-9. PubMed ID: 8262670
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Advances in research on DT-diaphorase--catalytic properties, regulation of activity and significance in the detoxication of foreign compounds.
    Horie S
    Kitasato Arch Exp Med; 1990 Apr; 63(1):11-30. PubMed ID: 2125671
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of a set of Chinese hamster ovary variant cell lines demonstrating differing sensitivity to mitomycin C.
    Kuehl BL; Buchwald M; Rauth AM
    Oncol Res; 1993; 5(6-7):213-21. PubMed ID: 8123941
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Establishment by adriamycin exposure of multidrug-resistant rat ascites hepatoma AH130 cells showing low DT-diaphorase activity and high cross resistance to mitomycins.
    Wakusawa S; Nakamura S; Miyamoto K
    Jpn J Cancer Res; 1997 Jan; 88(1):88-96. PubMed ID: 9045901
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alternative splicing and differential expression of DT-diaphorase transcripts in human colon tumors and in peripheral mononuclear cells in response to mitomycin C treatment.
    Yao KS; Godwin AK; Johnson C; O'Dwyer PJ
    Cancer Res; 1996 Apr; 56(8):1731-6. PubMed ID: 8620484
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Isolation and characterization of a mitomycin C-resistant variant of human colon carcinoma HT-29 cells.
    Lee JH; Naito M; Nakajima M; Tsuruo T
    Cancer Chemother Pharmacol; 1993; 33(3):215-20. PubMed ID: 7505723
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Involvement of activator protein-1 and nuclear factor-kappaB transcription factors in the control of the DT-diaphorase expression induced by mitomycin C treatment.
    Yao KS; Hageboutros A; Ford P; O'Dwyer PJ
    Mol Pharmacol; 1997 Mar; 51(3):422-30. PubMed ID: 9058597
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of mammalian DT-diaphorase in Escherichia coli: purification and characterization of the expressed protein.
    Ma Q; Wang R; Yang CS; Lu AY
    Arch Biochem Biophys; 1990 Dec; 283(2):311-7. PubMed ID: 1703398
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NAD(P)H:quinone oxidoreductase expression and mitomycin C resistance developed by human colon cancer HCT 116 cells.
    Pan SS; Forrest GL; Akman SA; Hu LT
    Cancer Res; 1995 Jan; 55(2):330-5. PubMed ID: 7812966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. pH-dependent inactivation of DT-diaphorase by mitomycin C and porfiromycin.
    Siegel D; Beall H; Kasai M; Arai H; Gibson NW; Ross D
    Mol Pharmacol; 1993 Dec; 44(6):1128-34. PubMed ID: 8264549
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of DT-diaphorase in cancer chemoprevention and chemotherapy.
    Begleiter A; Leith MK; Curphey TJ; Doherty GP
    Oncol Res; 1997; 9(6-7):371-82. PubMed ID: 9406243
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of NAD(P)H:(quinone acceptor) oxidoreductase (DT-diaphorase) in activation of mitomycin C under acidic conditions.
    Begleiter A; Leith MK
    Mol Pharmacol; 1993 Jul; 44(1):210-5. PubMed ID: 8341273
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of DT-diaphorase and cytochrome P450 reductase correlates with mitomycin C activity in human bladder tumors.
    Gan Y; Mo Y; Kalns JE; Lu J; Danenberg K; Danenberg P; Wientjes MG; Au JL
    Clin Cancer Res; 2001 May; 7(5):1313-9. PubMed ID: 11350900
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predicting tumor responses to mitomycin C on the basis of DT-diaphorase activity or drug metabolism by tumor homogenates: implications for enzyme-directed bioreductive drug development.
    Phillips RM; Burger AM; Loadman PM; Jarrett CM; Swaine DJ; Fiebig HH
    Cancer Res; 2000 Nov; 60(22):6384-90. PubMed ID: 11103802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bioactivation of mitomycin antibiotics by aerobic and hypoxic Chinese hamster ovary cells overexpressing DT-diaphorase.
    Belcourt MF; Hodnick WF; Rockwell S; Sartorelli AC
    Biochem Pharmacol; 1996 Jun; 51(12):1669-78. PubMed ID: 8687482
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of the relationship between genotypic status of a DT-diaphorase point mutation and enzymatic activity.
    Misra V; Grondin A; Klamut HJ; Rauth AM
    Br J Cancer; 2000 Oct; 83(8):998-1002. PubMed ID: 10993645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of NAD(P)H:(quinone acceptor) oxidoreductase (DT-diaphorase) in activation of mitomycin C under hypoxia.
    Begleiter A; Robotham E; Leith MK
    Mol Pharmacol; 1992 Apr; 41(4):677-82. PubMed ID: 1373799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.